A federal government advisory body has refused to recommend listing a new Alzheimer’s drug, leaving patients to bear ...

While the United States remains a major market due to advanced research and telemedicine adoption (CAGR: 4.5%), Asia-Pacific ...

The Cleveland Clinic's Nathan Pennell, M.D., Ph.D., is switching to the Big Pharma realm to head up hematology and oncology ...